SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS CEO Angelos Stergious 15th-anniversary LinkedIn post prompted speculation that its next chapter language hinted at REGAL trial news or a buyout, while skeptics viewed it as routine reassurance. The main focus remains the blinded Phase 3 REGAL trial, last publicly reported at 78 of the 80 deaths needed to trigger final analysis; neither the outcome nor a potential deal is confirmed.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs steep decline to new lows is being discussed alongside concerns about Trumps falling approval and the approaching midterms, with traders also pointing to weak business fundamentals and Truth Social engagement. The conversation is overwhelmingly bearish, though some see the selloff as a potential trading opportunity.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff has focused discussion on its heavy debt, costly financing needs and insider selling, alongside concerns about broader weakness in AI infrastructure stocks. Traders are split between fears of dilution or default and hopes that contracted AI demand, analyst support and buying near recent lows could underpin a recovery.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention as traders position around its Q3 earnings report, with options activity reflecting uncertainty rather than a clear directional consensus. The debate weighs weaker vehicle sales and EV demand against expectations that pricing and product mix could support profitability.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCells Fit Energy data-center project and broader AI-driven demand for on-site power are fueling interest, alongside expectations for a manufacturing ramp and discussion of elevated short interest. Bulls point to the project pipeline and Alex Meruelos reported 7.5% stake, while skeptics question whether opportunities will become firm orders and profitable execution amid dilution and management concerns.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Interim ARO-MAPT data showing substantial tau reduction after a subcutaneous dose has focused attention on whether Arrowheads RNAi platform can deliver treatments across the blood-brain barrier. Many traders view the results as important platform validation, while others are frustrated by the muted share-price response and debate how much value the CNS opportunity merits.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is drawing attention amid a sharp semiconductor pullback and rebound, with traders debating whether AI infrastructure spending and debt-backed data-center expansion can generate adequate returns. Bearish concerns about financing and profitabilityespecially around CoreWeavecontrast with dip-buyers pointing to continued compute demand and Nvidias quantum-computing work.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealths better-than-expected quarterly results and raised full-year outlook, alongside improved medical-cost trends, are driving attention. Bulls view the report as evidence of a turnaround and point to defensive-sector demand, while skeptics note the post-earnings selloff and lingering concerns about Medicare Advantage costs and regulatory risks.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers recent climb to a 52-week high is drawing attention as traders watch for a break above the $30 level, citing product and pipeline progress, including an expanded Tukysa indication and clinical updates. Bulls see a turnaround supported by defensive-sector interest and the dividend, while skeptics question the rallys durability given patent-expiration concerns and resistance near $30.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

CRDO is drawing attention after a sharp, volatile pullback alongside weakness in AI and semiconductor stocks; traders debate whether the decline is sector-driven or compounded by insider share-sale filings and valuation concerns. Bulls point to AI data-center connectivity demand and view the dip as a buying opportunity, while bears remain wary of further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

After a Streak Not Seen Since 2008, Bank Stocks Face a Five-Day Test

After a Streak Not Seen Since 2008, Bank Stocks Face a Five-Day Test After a Streak Not Seen Since 2008, Bank Stocks Face a Five-Day TestPR NewswireNEW YORK, Oct. 19, 2026 NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Equity Insider News Commentary- The 24-member KBW Bank Index was on course Friday for a...

Countdown to Northern Trust (NTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Northern Trust (NTRS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.

Truist Financial Corporation (TFC) Q3 Earnings and Revenues Miss Estimates

Truist Financial (TFC) delivered earnings and revenue surprises of -0.86% and -2.19%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Northern Trust Corporation (NTRS) Earnings Expected to Grow: Should You Buy?

Northern Trust (NTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Northern Trust Corporation (NTRS) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Northern Trust (NTRS) have what it takes? Let's find out.

UBS to Deepen NTRS Tie-Up With Credit Suisse Fund Administration Deal

UBS Group is set to transfer former Credit Suisse fund administration businesses to Northern Trust, deepening their partnership while simplifying operations.

Northern Trust Wealth Management Continues Northeast Region Expansion with Two Senior Appointments

Northern Trust Wealth Management has appointed Beth Emswiler and Andrew Borner as Senior Managing Directors in the Northeast Region. Emswiler is based in New York, while Borner is based in Greenwich, Connecticut, strengthening the firms investment capabilities and client leadership in both markets...

IBRX Stock Racks Up 3 Straight Quarterly Wins: Q3 Filings Reveal BlackRock Closing In On Vanguard With A Bigger Bet

Equity

Vanguard’s six reporting entities collectively held 36.48 million shares after adding a net 2.43 million during Q2.

Northern Trust Announces Chief Financial Officer Transition

Northern Trust Corporation announced today that Dave Fox, Chief Financial Officer, has announced his retirement after a long and distinguished career in financial services. Fox intends to remain in his role through the end of the first quarter of 2027 to support a thoughtful and orderly transition...

Northern Trust Asset Management Plans to Convert Six Mutual Funds to ETFs

Northern Trust Asset Management, a leading global investment management firm with US$1.6 trillion in assets under management as of June 30, 2026, announced plans to convert six Northern Trust mutual funds into ETFs in the first quarter of 2027. The conversions are intended to benefit shareholders...

Northern Trust Corp. is a financial holding company, which engages in the provision of asset servicing, fund administration, asset management, fiduciary, and banking solutions for corporations, institutions, families, and individuals. It operates through the Asset Servicing and Wealth Management segments. The Asset Servicing segment offers asset servicing, brokerage, banking and related services to corporate and public retirement funds, foundations, endowments, fund managers, insurance companies and sovereign wealth funds. The Wealth Management Segment includes trust, investment management, custody, and philanthropic services, financial consulting, guardianship and estate administration, family business consulting, family financial education, brokerage services and private and business banking. The company was founded on August 12, 1889 and is headquartered in Chicago, IL.

Northern Trust Corp.

Neutral Sentiment

<ul class="summary-bullets"><li>BlackRock added 7.74 million shares, narrowing Vanguard’s lead to 2.4 million shares.</li><li>Two Sigma boosted its holding by 153%, while State Street, Geode and Northern Trust also reported substantial increases.</li><li>Susquehanna, Jane Street and Citadel cut their reported share holdings by 94%, 90% and 55%.</li></ul><p>Shares of ImmunityBio, Inc. (<a class="mention" data-mention="$IBRX" data-symbol-id="IBRX" href="https://stocktwits.com/symbol/IBRX" target="_blank">IBRX</a>) logged their third consecutive quarterly gain as institutional disclosures released during Q3 revealed that BlackRock had narrowed the gap with Vanguard’s combined holdings, adding more than three times as many shares.</p><p><a href="https://stocktwits.com/symbol/IBRX">IBRX stock</a> jumped 7% to $9.44 on Wednesday, hitting a seven-month high. Shares gained 19% in September, their best month since February, and finished Q3 up 8%.</p><h2 class="st-heading-2"><strong>BlackRock Narrows Vanguard’s Lead</strong></h2><p>Filings released during Q3 showed that BlackRock and Vanguard increased their <a class="mention" data-mention="$IBRX" data-symbol-id="IBRX" href="https://stocktwits.com/symbol/IBRX" target="_blank">IBRX</a> holdings in Q2.&nbsp; BlackRock added 7.74 million shares, increasing its position by 29% to 34.08 million shares, valued at $298.4 million. Vanguard’s six reporting entities collectively held 36.48 million shares, up a net 2.43 million, or about 7%, from March 31.</p><p>BlackRock added about 3.18 times as many shares as Vanguard’s six entities combined. This narrowed Vanguard’s lead from about 7.7 million shares at the end of March to 2.4 million at the end of June.</p><p>Vanguard Portfolio Management made the group’s largest addition, adding 1.54 million shares to hold 17.86 million. Vanguard Capital Management added 563,865 shares to reach 15.69 million, while Vanguard Fiduciary Trust added 289,210 shares to hold 2.41 million.</p><p>Vanguard Asset Management and Vanguard Global Advisers added 26,065 and 9,073 shares. Vanguard Personalized Indexing Management trimmed its holding by 2,298 shares, leaving the group’s combined net increase at 2.4 million shares.</p><h2 class="st-heading-2"><strong>Two Sigma Leads A Wave Of Stake Increases</strong></h2><p>BlackRock was not the only large investor to disclose a substantial increase. Two Sigma Investments boosted its position by 153%, adding 6.71 million shares to hold 11.1 million. Its position was valued at $97.2 million as of June 30.</p><p>State Street added 3.69 million shares, increasing its holding by 21% to 21.4 million. Geode Capital Management added 1.82 million shares, while Northern Trust increased its position by 1.06 million.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col><col></colgroup><tbody><tr><td>Investor</td><td>Shares held on June 30</td><td>Shares added during Q2</td><td>Position increase</td></tr><tr><td>BlackRock</td><td>34.1 million</td><td>7.7 million</td><td>29%</td></tr><tr><td>Vanguard - six entities combined</td><td>36.5 million</td><td>2.4 million</td><td>7%</td></tr><tr><td>Two Sigma Investments</td><td>11.1 million</td><td>6.7 million</td><td>153%</td></tr><tr><td>State Street</td><td>21.4 million</td><td>3.7 million</td><td>21%</td></tr><tr><td>Geode Capital Management</td><td>9.8 million</td><td>1.8 million</td><td>23%</td></tr><tr><td>Northern Trust</td><td>3.6 million</td><td>1.1 million</td><td>42%</td></tr></tbody></table></figure></div><p>Together, these investors reported about 23.44 million additional shares compared with the previous quarter.</p><p>Other notable increases included BNY Mellon, which added 483,330 shares to hold 1.31 million, a 58% increase. Citigroup expanded its position by 227%, adding 381,920 shares to reach 550,276. Marshall Wace increased its holding by 403% to 387,700 shares, while T. Rowe Price Associates added 146,613 shares, lifting its position by 50% to 441,444.</p><h2 class="st-heading-2"><strong>Jane Street And Susquehanna Slash Holdings</strong></h2><p>The institutional picture was mixed, with substantial additions alongside sharp reductions. D. E. Shaw reduced its position by 1.02 million shares, or 8%, but retained a sizable holding of 11.55 million shares. Morgan Stanley trimmed its position by 586,191 shares to 3.43 million, a 15% decline.</p><p>Woodline Partners cut its holding by 28% to 2.5 million shares, while Voleon Capital Management reduced its position by 53% to 549,126.</p><p>Several trading firms made even steeper percentage reductions:</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col><col></colgroup><tbody><tr><td>Investor</td><td>Shares held on June 30</td><td>Shares reduced during Q2</td><td>Position reduction</td></tr><tr><td>Susquehanna International Group</td><td>65,961</td><td>1.1 million</td><td>94%</td></tr><tr><td>Jane Street Group</td><td>72,397</td><td>631,835</td><td>90%</td></tr><tr><td>Tower Research Capital</td><td>19,753</td><td>52,760</td><td>73%</td></tr><tr><td>Virtu Financial</td><td>67,774</td><td>194,524</td><td>74%</td></tr><tr><td>Citadel Advisors</td><td>136,045</td><td>169,533</td><td>55%</td></tr></tbody></table></figure></div><h2 class="st-heading-2"><strong>FDA Decision And Tokenization Plans Draw Attention</strong></h2><p>The disclosures came as investors weighed Anktiva’s expanding reach and founder Patrick Soon-Shiong’s tokenization ambitions. Anktiva, the company’s flagship immunotherapy, is approved or authorized across 34 countries, with an FDA decision on expanding its U.S. bladder-cancer label to papillary-only patients expected by Jan.6, 2027.</p><p>A September patent application outlined potential uses to restore immune cells depleted by cancer treatments, potentially allowing patients to continue earlier therapies. “As such, even failed treatments can be continued,” the application said.&nbsp;</p><p>Meanwhile, Soon-Shiong teased blockchain-based trading at Nant: “The future is here. Watch this space as we launch blockchain and tokenized stocks at Nant.” Nant Global Finance is assembling trading and settlement infrastructure, drawing retail speculation that tokenization could curb so-called phantom shares and pressure short sellers.&nbsp;</p><h2 class="st-heading-2"><strong>How Do Retail Traders Feel About <a class="mention" data-mention="$IBRX" data-symbol-id="IBRX" href="https://stocktwits.com/symbol/IBRX" target="_blank">IBRX</a>?</strong></h2><p>On Stocktwits, retail sentiment for <a class="mention" data-mention="$IBRX" data-symbol-id="IBRX" href="https://stocktwits.com/symbol/IBRX" target="_blank">IBRX</a> jumped to ‘extremely bullish’ from ‘bullish’ levels a day ago amid a 237% surge in 24-hour message volumes. After Wednesday’s rally, several users questioned whether the unusual price action signaled an imminent announcement.</p><figure class="image"><img src="https://news.stocktwits-cdn.com/ibrx_ss_c49fc37055.png" alt="ibrx ss.png" width="643" height="347"><figcaption><a class="mention" data-mention="$IBRX" data-symbol-id="IBRX" href="https://stocktwits.com/symbol/IBRX" target="_blank">IBRX</a> sentiment and message volume as of September 30 | Source: Stocktwits</figcaption></figure><p>“This move is very unusual. Something is already materialized behind the scene and to be PR soon,” one user<a href="https://stocktwits.com/TonTiff/message/665442295">&nbsp;said</a>. Another<a href="https://stocktwits.com/Floridahurricanehater/message/665476647">&nbsp;asked</a>, “News. Tommorrow???? Somebody knows something!!!” A third trader<a href="https://stocktwits.com/Justomh570/message/665502158">&nbsp;pointed</a> to above-average trading volume without substantial news, speculating that something could emerge “very very soon.”</p><p><a class="mention" data-mention="$IBRX" data-symbol-id="IBRX" href="https://stocktwits.com/symbol/IBRX" target="_blank">IBRX</a> stock has jumped 378% year-to-date.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/asts-bluebird-convoy-cape-canaveral-ceo-pitches-spectrum-fcc-chief/cZDiFKLRBLn">ASTS Climbs Overnight As BlueBird Convoy Heads To Cape Canaveral, CEO Pitches Spectrum To FCC Chief&nbsp;</a></p>

In this photo illustration, the ImmunityBio (Immunity Bio) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Blackrock Inc.

Citigroup Inc

ImmunityBio Inc

Morgan Stanley

State Street Corp.

T. Rowe Price Group Inc.

Virtu Financial Inc - Ordinary Shares - Class A

SPDR S&P Biotech ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$164.46
Prev Close	$165.54
Open	$165.60
Dividend Yield	2.27%
50-Day Moving Average	$179.10
Beta	1.01
Avg. Volume	1.02M
PE Ratio	14.12

52-Week High	$195.78
52-Week Low	$121.53
Market Capitalization	$30.29B
EPS (Annual)	$8.73
Price to Book	2.40
Revenue Per Employee	$602,058.82

Feed

News

Sentiment

Earnings

Fundamentals

Info

NTRS Fundamentals